Skip to main content
. 2017 Jun 13;8(46):81321–81328. doi: 10.18632/oncotarget.18466

Table 1. Basic characteristics of the study participants.

Control individuals Cirrhotic individuals
No cirrhosis (n = 37 252) All (9 313) Nonalcoholic n = 7 064 Alcoholic n = 2 249
Sex, n (%)#
Male 26 260 (70.49) 6 565 (70.49) 4 474 (63.34) 2 091 (92.97)
Female 10 992 (29.51) 2 748 (29.51) 2 590 (36.66) 158 (7.03)
Age in 2005 (Mean±SD) 54.49±14.92 54.49±14.92 56.87±15.06 47±11.65
Low-income, n (%)*,#
No 36 972 (99.25) 9 144 (98.19) 6 975 (98.74) 2 169 (96.44)
Yes 280 (0.75) 169 (1.81) 89 (1.26) 80 (3.56)
Residents, n (%)*,#
Urban 21 729 (58.33) 4 913 (52.75) 3 823 (54.12) 1 090 (48.47)
Sub-urban 11 601 (31.14) 3 060 (32.86) 2 285 (32.35) 775 (34.46)
Rural 3 922 (10.53) 1 340 (14.39) 956 (13.53) 384 (17.07)
Comorbidity, n (%)
Hepatitis B*,# 790 (2.12) 2 080 (22.33) 1 750 (24.77) 330 (14.67)
Hepatitis C*,# 298 (0.80) 1 528 (16.41) 1 356 (19.2) 172 (7.65)
Unspecified hepatitis*,# 4 753 (12.76) 5 564 (59.74) 4 325 (61.23) 1 239 (55.09)
Dyslipidemia* 4 638 (12.45) 1 551 (16.65) 1 192 (16.87) 359 (15.96)
Hypertension*,# 9 662 (25.94) 3 107 (33.36) 2 580 (36.52) 527 (23.43)
COPD*,# 6 695 (17.97) 2 207 (23.7) 1 846 (26.13) 361 (16.05)
Cerebrovascular disease*,# 2 795 (7.50) 961 (10.32) 823 (11.65) 138 (6.14)
Myocardial infarction* 322 (0.86) 104 (1.12) 85 (1.2) 19 (0.84)
Renal disease*,# 1 257 (3.37) 709 (7.61) 627 (8.88) 82 (3.65)

Included alcoholic cirrhosis and cirrhosis without alcohol

*Significantly different between cirrhotic and comparison patients, p < 0.05

#Significantly different between patients with alcoholic cirrhosis and cirrhosis without alcohol p < 0.05